Alefacept in the treatment of psoriatic nail disease: a proof of concept study
Parrish, C.A.; Sobera, J.O.; Robbins, C.M.; Cantrell, W.C.; Desmond, R.A.; Elewski, B.E.
Journal of Drugs in Dermatology Jdd 5(4): 339-340
2006
ISSN/ISBN: 1545-9616 PMID: 16673801 Document Number: 8226
Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.
Document emailed within 1 workday